Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2025.
Financials
Financial year 2025
PHARMACIE RONLEZ from Ath, company number BE0898511988, closed financial year 2025 with a result of € -64,745 after tax. For that financial year PHARMACIE RONLEZ recorded a gross margin of € 531,150 and equity of € 707,121. Compared with financial year 2024, the result moved from € 149,635 to € -64,745. The company made a loss. The buffer shrank hard: equity is 51 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 5, 2026.
€ 707,121
▼ 51% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -64,745
▼ still € 149,635 profit in 2024
Profit after tax over the fiscal year.
€ 463,591
▼ 18% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 688,521.
People and assets in 2025
5.8
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 287,628
▲ 12% vs 2024
€ 49,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 12,082
▲ 154% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 351,338
▼ 17% vs 2024
€ 79,552 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 168,114
▼ 41% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 61,751
▲ 23% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 582,917 | € 506,001 | € 553,836 | € 531,150 | ▼ 4% |
| Profit after taxes | € 158,445 | € 107,649 | € 149,635 | € -64,745 | ▼ € 214,380 |
| Equity | € 1,193,196 | € 1,298,634 | € 1,445,866 | € 707,121 | ▼ 51% |
| Total debts | € 1,110,985 | € 892,835 | € 763,371 | € 1,255,424 | ▲ 64% |
| Cash | € 414,261 | € 291,512 | € 563,972 | € 463,591 | ▼ 18% |
| Land & buildings | € 463,294 | € 418,338 | € 373,382 | € 328,426 | ▼ 12% |
| Retained profit | € 1,174,596 | € 1,280,034 | € 1,427,266 | € 688,521 | ▼ 52% |
| Dividend | € 0 | € 0 | € 0 | € 674,000 | |
| Bank debt | € 580,688 | € 512,547 | € 423,724 | € 351,338 | ▼ 17% |
| Balance sheet total | € 2,304,181 | € 2,191,469 | € 2,209,236 | € 1,962,545 | ▼ 11% |
| Employees (FTE) | 5.7 | 5 | 5.7 | 5.8 | ▲ 0.1 |
Key figures of PHARMACIE RONLEZ, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE RONLEZ?
What happened at PHARMACIE RONLEZ in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Corrected annual accounts filed for financial year 2025. filed late Source: NBB ↗
- CHARLES RONLEZ became a director. NBB
- CHRISTOPHE RONLEZ became a director. NBB
- SOPHIE GHISBAIN became a director. NBB
- BRIGITTE HOET became a director. NBB
- New establishment in Ath. KBO
- Start of the company according to the CBE. KBO
In short
From € 158,445 profit in 2022 to € 64,745 loss in 2025.
Paid € 247,976 in corporate taxes since 2022.
Best year ever: 2022, with € 158,445 profit.
On average € 91,600 of value added per employee in 2025.
A new publication or filing at PHARMACIE RONLEZ? We notify you, reason included.
Follow PHARMACIE RONLEZDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIE RONLEZ are CHARLES RONLEZ, CHRISTOPHE RONLEZ, SOPHIE GHISBAIN and BRIGITTE HOET. It owns 20% of Kluiz Immo itself.
Directors
According to the 2025 annual accounts
since 2011
CHRISTOPHE RONLEZ
Director
since 2011
since 2011
BRIGITTE HOET
Director
since 2011
Establishments
Establishment units
Physical locations of this company
Chaussée de Grammont(GHI) 55
7822 Ath
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0898.511.988
- VAT number
- BE 0898.511.988
- Registered office
- Chaussée de Grammont(GHI) 55, 7822 Ath
- Names & denominations
- PHARMACIE RONLEZ
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 June 2008
- Peppol
- Active · Active since 26 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering